Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > i like the opening

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Oct 23, 2023 11:56am

238 Views

Post# 35696407

RE:i like the opening

Yes, it's very encouraging. I think "clinical development" = BTD and "commercialization program" = AA and jv.

Given all the recent good news and forward-thinking from Theralase I think things are back on track.

m8magic wrote: Arkady Mandel, MD, PhD, DSc, Chief Scientific Officer of Theralase® stated, "Based on our latest published clinical results in Study II, we are quickly approaching a critical stage in our NMIBC clinical development and commercialization program.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?